Ecofibre Ltd Market Cap ($5.36 Million)
Market Cap & Net Worth: Ecofibre Ltd (EOF)
Ecofibre Ltd market cap. Ecofibre Ltd (AU:EOF) has a market capitalization of $5.36 Million (AU$7.58 Million) as of November 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #28366 globally and #1461 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ecofibre Ltd's stock price AU$0.02 by its total outstanding shares 378873984 (378.87 Million). Also see EOF cash generation efficiency for how efficiently the company converts equity into cash flow.
Ecofibre Ltd Market Cap History (2019–2025)
Ecofibre Ltd market cap history from 2019 to 2025. Data shows change from $713.09 Million to $5.36 Million (-49.92% CAGR). Check Ecofibre Ltd stock quote for real-time trading data and today's change.
Index Memberships
Ecofibre Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$2.00 Trillion | 0.00% | #328 of 495 |
Weight: Ecofibre Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ecofibre Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ecofibre Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Ecofibre Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.29x
Ecofibre Ltd's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $713.09 Million | $35.60 Million | $6.00 Million | 20.03x | 118.85x |
| 2020 | $510.69 Million | $50.72 Million | $13.16 Million | 10.07x | 38.82x |
| 2021 | $150.12 Million | $28.79 Million | -$6.99 Million | 5.21x | N/A |
| 2022 | $61.66 Million | $30.22 Million | -$14.67 Million | 2.04x | N/A |
| 2023 | $42.89 Million | $32.51 Million | -$39.91 Million | 1.32x | N/A |
| 2024 | $8.04 Million | $27.98 Million | -$44.34 Million | 0.29x | N/A |
Competitor Companies of EOF by Market Capitalization
Companies near Ecofibre Ltd in the global market cap rankings as of November 4, 2026. Also see Ecofibre Ltd total assets for a full breakdown of the balance sheet.
Key companies related to Ecofibre Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Ecofibre Ltd (2019–2025)
Market capitalization of Ecofibre Ltd from 2019 to today. Between 2019 and today, Ecofibre Ltd's market cap moved from $713.09 Million to $ 5.36 Million, with a yearly change of -49.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$5.36 Million | -33.33% |
| 2024 | AU$8.04 Million | -81.25% |
| 2023 | AU$42.89 Million | -30.43% |
| 2022 | AU$61.66 Million | -58.93% |
| 2021 | AU$150.12 Million | -70.60% |
| 2020 | AU$510.69 Million | -28.38% |
| 2019 | AU$713.09 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 28th, 2026 the market cap of Ecofibre Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.36 Million USD |
| MoneyControl | $5.36 Million USD |
| MarketWatch | $5.36 Million USD |
| marketcap.company | $5.36 Million USD |
| Reuters | $5.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ecofibre Ltd
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more